How It Is Studied In laboratory research, 5-Amino-1MQ is typically applied to cultured cell lines to assess changes in NNMT enzymatic activity via methyltransferase assays
Bond Peptides combines the best of science and precision
Send your logo and colors, and we ship it under your name
Room temperature storage causes significant potency loss within days for reconstituted solution and within weeks for powder
DOI: 10.3390/molecules191119066
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
